Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.88 -0.15 (1.66%)
Previous Close $9.03    52 Week High $9.23 
Open $9.07    52 Week Low $1.16 
Day High $9.30    P/E N/A 
Day Low $8.80    EPS $-0.30 
Volume 2,586,810       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.88 -0.15 (1.66%)
Previous Close $9.03    52 Week High $9.23 
Open $9.07    52 Week Low $1.16 
Day High $9.30    P/E N/A 
Day Low $8.80    EPS $-0.30 
Volume 2,586,810